Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
09/10/2008 | EP1451222B1 Proteins with il-6 inhibiting activity |
09/10/2008 | EP1438053B1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
09/10/2008 | EP1427708B1 Amino-phthalazinone derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
09/10/2008 | EP1368302B1 Novel amino dicarboxylic acid derivatives |
09/10/2008 | EP1285908B1 Substituted phenylpropionic acid derivatives |
09/10/2008 | EP1261337B1 Topoisomerase inhibitors for treatment of surgical adhesions |
09/10/2008 | EP1159006B1 Water-soluble compositions of bioactive lipophilic compounds |
09/10/2008 | EP1131356B1 Monoclonal anti alpha-D (ITGAD) antibody for use in the treatment of CNS injuries caused by trauma |
09/10/2008 | EP0871376B1 Use of locally administered lysine for enhancing vascular fonction |
09/10/2008 | CN101263114A Crystalline and amorphous sodium atorvastatin |
09/10/2008 | CN101262872A Novel inhibitor of vascular endothelial growth factor expression |
09/10/2008 | CN101262866A Hemodynamics improving agent |
09/10/2008 | CN101262864A Alcanoic acid amides substituted by saturated O-heterocycles |
09/10/2008 | CN101262858A Adhesive medicament preparation containing bisoprolol |
09/10/2008 | CN101260103A Compound with portion PPARgamma excitant activity and application thereof |
09/10/2008 | CN101260092A Method for preparing cinepazide maleate |
09/10/2008 | CN101259249A Chinese medicine preparation for treating head wind |
09/10/2008 | CN101259218A Chinese medicine preparation for treating vertigo |
09/10/2008 | CN101259213A Health drug pillow |
09/10/2008 | CN101259207A Coronary pill |
09/10/2008 | CN101259204A Medicaments for treating and preventing hypertension and preparation thereof |
09/10/2008 | CN101259192A Method for processing camellia chrysantha pollen |
09/10/2008 | CN101259179A Chinese medicine í«naodeshengí» soft capsule and preparation thereof |
09/10/2008 | CN101259174A Chinese medicine foot soaking agent for regulating blood pressure and improving sleeping quality |
09/10/2008 | CN101259164A Health care oral liquid for preventing and controlling hypertension |
09/10/2008 | CN101259159A Preparation of alhagi sparsifolia total flavones and uses thereof |
09/10/2008 | CN101259158A Chinese medicine pharmaceutical composition for treating coronary heart disease and preparation |
09/10/2008 | CN101259154A Effective component of ligusticum chuanxiong, saposhnikovia divaricata, dahurian angelica root for treating vascular diseases and its components compatibility formula |
09/10/2008 | CN101259150A Sustained-release pellet of ginkgo biloba extract and its preparation |
09/10/2008 | CN101259132A Aspirin dipyridamole sustained-release capsules and production method |
09/10/2008 | CN101259122A Use of hydroxyoleic acid and similar compounds in the production of medicaments |
09/10/2008 | CN101259121A Use of hydroxyoleic acid and similar compounds in the production of medicaments |
09/10/2008 | CN101259112A Sarpogrelate hydrochloride single layer osmotic pump regulated-release preparations and preparation thereof |
09/10/2008 | CN101259111A Compound sustained-release pellet tablet containing nifedipine and atenolol and preparation thereof |
09/10/2008 | CN101258875A Yoghourt useful for lowering blood fat and preparation |
09/10/2008 | CN100417727C Medical preparations for treatment of alpha-galactosidase A deficiency |
09/10/2008 | CN100417659C Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
09/10/2008 | CN100417418C Nucleic acid-containing complex |
09/10/2008 | CN100417395C Biological preparation capable of improving cardio cerebral function |
09/10/2008 | CN100417389C Medicine composition for treating microcirculation dysfunction and its preparing method |
09/10/2008 | CN100417388C Compound injection preparation containing ligustrazine and breviscapine and its preparation method |
09/10/2008 | CN100417387C Compound injection formulation compose dof borneol and pseudo-ginseng total saponin and its preparing method |
09/10/2008 | CN100417384C Herbeishatan hydrochlorothiazine dispersion tablet |
09/10/2008 | CN100417381C Nicorandil freeze-drying powder preparation method |
09/10/2008 | CN100417379C Nonsedating alpha-2 agonist 1- (2, 3-dimethyl-phenyl) -ethyl-1, 3-dihydro-imizadole-2-thione |
09/09/2008 | US7423177 Carboxamide derivatives as therapeutic agents |
09/09/2008 | US7423067 Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists |
09/09/2008 | US7423059 Pharmaceutically active compounds and methods of use |
09/09/2008 | US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
09/09/2008 | US7423052 Piperidine compounds for use as orexin receptor antagoinst |
09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
09/09/2008 | US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
09/09/2008 | US7423032 Method for treating severe heart failure and medicament therefor |
09/09/2008 | US7423020 Therapy for behavior disorders; quantitative analysis; measuring binding |
09/09/2008 | US7423014 Insulin conjugates for treating diabetes mellitus |
09/09/2008 | US7423011 Treating autoimmune diseases such as multiple sclerosis with CXCR4 antagonist such as peptides having of stromal cell derived factor one (SDF-1) sequences |
09/09/2008 | US7422846 Detecting the activity of orphan G Protein Receptor 86 by incubating a sample comprising GPR86 and adenosine diphosphate (ADP) under binding conditions for both and detecting a second messanger; screening for a modulator |
09/09/2008 | US7422744 Integrin mediated diseases like angiogenesis or restenosis; Vitaxin (a humanized monoclonal) antibody and a LM609 grafted antibody exhibiting selective binding affinity to alpha v beta 3 |
09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
09/09/2008 | CA2460865C Quinoline derivatives as neuropeptide y antagonists |
09/09/2008 | CA2397960C Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith |
09/09/2008 | CA2359357C Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
09/09/2008 | CA2346868C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
09/09/2008 | CA2345409C Phenylacetic acid compositions for treating or preventing atherosclerosis and restenosis |
09/09/2008 | CA2336712C Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
09/09/2008 | CA2323086C Regulation of endogenous gene expression in cells using zinc finger proteins |
09/09/2008 | CA2252163C D-proline derivatives |
09/09/2008 | CA2211646C Substituted phenyl compounds as endothelin antagonists |
09/09/2008 | CA2181689C Guanylhydrazones for treating inflammatory conditions |
09/09/2008 | CA2162299C Pharmaceutical composition for oral delivery of flavonoids |
09/04/2008 | WO2008106633A1 Methods of using benzodioxine compounds in treating sodium channel-mediated diseases or conditions |
09/04/2008 | WO2008106569A1 Renin inhibitors for the treatment of hypertension in patients with high sodium diet |
09/04/2008 | WO2008105968A1 Novel seh inhibitors and their use |
09/04/2008 | WO2008105794A1 Process for the purification of carvedilol or its salts thereof |
09/04/2008 | WO2008105731A1 New use of nitrites and nitrates and compositions containing these |
09/04/2008 | WO2008105560A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
09/04/2008 | WO2008105533A1 Adiponectin secretion-stimulating agent comprising capsinoid compound |
09/04/2008 | WO2008105526A1 Macrocyclic compound |
09/04/2008 | WO2008105436A1 TUMOR NECROSIS FACTOR-α INHIBITOR AND PROSTAGLANDIN SYNTHASE-2 INHIBITOR |
09/04/2008 | WO2008105408A1 Novel pyrrole derivative having ureide group and aminocarbonyl group as substituents |
09/04/2008 | WO2008105392A1 3-amino-2-indolylbutyrolactam derivative, process for production of the same, and pharmaceutical agent comprising the same as active ingredient |
09/04/2008 | WO2008105384A1 Citrulline-containing tablet |
09/04/2008 | WO2008105325A1 Citrulline-containing beverage |
09/04/2008 | WO2008105260A1 Therapeutic agent for ameliorating prognosis after lower limb amputation surgery |
09/04/2008 | WO2008104976A1 Amphipathic carboxylates for the treatment of immune-related disorders |
09/04/2008 | WO2008104975A2 Combination therapy, composition and methods for the treatment of cardiovascular disorders |
09/04/2008 | WO2008104789A1 Therapeutic compositions |
09/04/2008 | WO2008104512A2 Novel polymorphs of aprepitant and processes for preparation |
09/04/2008 | WO2008104306A2 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof |
09/04/2008 | WO2008104279A1 Imidazo[1,2-a]azines and their use as pharmaceuticals |
09/04/2008 | WO2008104278A1 Imidazo[1,2-a] pyridines and their use as pharmaceuticals |
09/04/2008 | WO2008104200A1 Use of apyrase for the treatment of a pathology resulting from endotoxin activity |
09/04/2008 | WO2008104199A1 Use of ecto-phosphatases for the treatment of (acute) myocardial infarction |
09/04/2008 | WO2008104194A1 Oxidized ldl and antibodies thereto for the treatment of atheroscleroti c plaques |
09/04/2008 | WO2008104124A1 Screening method of combination pharmaceuticals, pharmaceuticals obtained by the method and uses thereof |
09/04/2008 | WO2008104064A1 Compositions and methods for treating peripheral vascular diseases |
09/04/2008 | WO2008061966A8 New use of flibanserin |
09/04/2008 | WO2008055310A8 Process for the preparation of angiogenin |
09/04/2008 | WO2008040361A3 Use of a combination of hypothermia inducing drugs |
09/04/2008 | US20080214812 Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition |